Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-27

Clinical Trial Update: Suvorexant and Sleep/Delirium in ICU Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial examining suvorexant for sleep issues and delirium in ICU patients has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belsomra (suvorexant)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Insomnia, Sleep Fragmentation | Phase 4 | Status: COMPLETED | Results posted: 2025-10-27